Romania's Antibiotice wins major UK public contract for injectable antibiotics
<p>Romanian pharmaceutical producer Antibiotice Iași (BVB: ATB) announced that it secured its fifth consecutive contract with the United Kingdom's National Health Service (NHS), significantly increasing its presence in the British market for injectable beta-lactam antibiotics.</p>

<p>The agreement involves the supply of seven million vials of five types of sterile injectable penicillins to UK hospitals over a two-year period. These antibiotics are among the most widely prescribed medicines in the country.&nbsp;</p>

<p>Following the latest tender, Antibiotice expects to raise its UK market share for this category to 43%, up from 35% in 2021, positioning the company among Europe's leading producers of sterile injectable penicillins.</p>

<p>The NHS contract is highly competitive, with participation from major manufacturers across Europe and India. Antibiotice's growing presence reflects the company's capacity and consistency in supplying essential medicines to high-standard healthcare systems.</p>

<p>In addition to its success in the UK, Antibiotice has recently expanded into other key European markets. The company won a public tender in Italy to supply approximately 400,000 vials of antibiotics annually, projecting a 40% market share for the targeted molecule segment.</p>

<p>This year, Antibiotice will also enter Germany - the European Union's largest pharmaceutical market - by supplying sterile injectable antibiotics. The company targets annual sales of 2.5 million vials in Germany, with hospital deliveries expected to begin in the fourth quarter of 2025.</p>

<p>Commercial negotiations are also ongoing in Spain, Poland, Hungary, the Czech Republic, and Slovakia, where Antibiotice aims to launch products that are already authorized.&nbsp;</p>

<p>Efforts are also underway to expand into new markets, including Croatia, France, and Austria.</p>

<p><em>iulian@romania-insider.com</em></p>

<p><em>(Photo source: Antibiotice.ro)</em></p>